Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
Home Partners CrystalsFirst GmbH

CrystalsFirst GmbH


Address
Marbacher Weg 6
City
Marburg
Country
Germany
ZIP
35037
Web page

About

Crystallographic fragment screening and enhanced structural biology platform.

CrystalsFirst’s proprietary technology platform generates rapid high-quality insights into drug-target-interactions. The co-structure determination process - from protein crystal to 3D model - is accelerated by the factor of 5 to 10.

Applications are crystallographic fragment screen for FBDD and structural validation of hits from orthogonal screening techniques. Deliverables of crystallographic fragment screen are high hit rates, access to new chemical space for IP, and new modes of actions for early drug discovery.